Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20
Recent study discovered heterozygous somatic mutations in the genes encoding isocitrate dehydrogenase-1 and -2 (IDH1 and IDH2) and these mutations could disable the enzymes' ability to convert 2-ketoglutarate to D-α-hydroxyglutarate
but by 72 h
mTOR integrates signals from proteins
20 days) administers 15 min before morphine injection can significantly decrease the effect of the morphine challenge dose in mice in comparison with the sporadically morphine-treated group
BRITE-338733 3-glucoside chloride Recent study discovered heterozygous somaticBRITE 338733 is a RecA ATPase inhibitor, with an IC50 of 4. 7 M. Product information CAS Number: 503105 88 2 Molecular Weight: 433. 59 Formula: C27H35N3O2 Chemical Name: 2 [4 (5 ethylfuran 2 yl) 6 [(2,2,6,6 tetramethylpiperidin 4 yl)amino]pyridin 2 yl] 4 methylphenol Smiles: CC1C=C(C(O)=CC=1)C1=CC(=CC(NC2CC(C)(C)NC(C)(C)C2)=N1)C1=CC=C(CC)O1 InChiKey: PKYYVDCUXJXUPN UHFFFAOYSA N InChi: InChI=1S C27H35N3O2 c1 7 20 9 11 24(32 20)18 13 22(21 12 17(2)8 10
US$ 100.00
US$ 3399.50
US$ 200.00